Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AD
12251
CALL
Array Digital Infrastructure
AD
$3.11B
| $43.5K | ﹤0.01% |
2,100
-1,200
| -36% | -$26.8K |
|
|
PFC
12252
CALL
DELISTED
Premier Financial Corp. Common Stock
PFC
| $43.5K | ﹤0.01% |
+2,100
| New | +$51.3K |
|
12253
BioCardia
BCDA
$14.7M
| $43.5K | ﹤0.01% |
1,479
+707
| +92% | +$23.5K |
|
|
SGMA
12254
DELISTED
Sigmatron International
SGMA
| $43.5K | ﹤0.01% |
16,526
-32,883
| -67% | -$120K |
|
|
BCLI
12255
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $43.5K | ﹤0.01% |
878
-220
| -20% | -$6.38K |
|
12256
PUT
Dakota Gold
DC
$836M
| $43.4K | ﹤0.01% |
12,000
+11,100
| +1,233% | +$36.7K |
|
|
PBPB
12257
CALL
DELISTED
Potbelly
PBPB
| $43.3K | ﹤0.01% |
5,200
+1,300
| +33% | +$9.78K |
|
12258
Barnwell Industries
BRN
$13.9M
| $43.3K | ﹤0.01% |
19,686
-3,224
| -14% | -$8.01K |
|
|
ARBK
12259
CALL
Argo Blockchain
ARBK
$42.1M
| $43.3K | ﹤0.01% |
120
+7
| +6% | +$2.56K |
|
|
NBP
12260
CALL
NovaBridge Biosciences American Depositary Shares
NBP
$227M
| $43.3K | ﹤0.01% |
12,500
-5,600
| -31% | -$27.1K |
|
|
DDL
12261
CALL
Dingdong
DDL
$523M
| $43.2K | ﹤0.01% |
+11,200
| New | +$54.2K |
|
|
MTLS
12262
PUT
Materialise
MTLS
$400M
| $43.2K | ﹤0.01% |
5,200
-20,100
| -79% | -$181K |
|
|
AGTI
12263
CALL
DELISTED
Agiliti Inc
AGTI
| $43.1K | ﹤0.01% |
2,700
+2,000
| +286% | +$34.4K |
|
|
NOTE
12264
DELISTED
FiscalNote
NOTE
| $43.1K | ﹤0.01% |
+1,610
| New | +$65.5K |
|
|
FRMM
12265
Forum Markets
FRMM
$80.4M
| $43.1K | ﹤0.01% |
+126
| New | +$73.2K |
|
|
EPIX
12266
CALL
DELISTED
ESSA Pharma
EPIX
| $43.1K | ﹤0.01% |
14,500
-9,400
| -39% | -$27.6K |
|
12267
CALL
Absci
ABSI
$1.58B
| $43K | ﹤0.01% |
24,600
+18,100
| +278% | +$43.8K |
|
12268
CALL
Precigen
PGEN
$2.18B
| $42.9K | ﹤0.01% |
40,500
-39,800
| -50% | -$57.4K |
|
12269
CALL
First Trust Global Wind Energy ETF
FAN
$285M
| $42.9K | ﹤0.01% |
2,400
-1,700
| -41% | -$30.1K |
|
|
SCWX
12270
PUT
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $42.9K | ﹤0.01% |
5,000
+3,700
| +285% | +$28.5K |
|
12271
Vanguard Extended Market ETF
VXF
$32.3B
| $42.8K | ﹤0.01% |
305
-31,517
| -99% | -$4.47M |
|
12272
PUT
TherapeuticsMD
TXMD
$24M
| $42.8K | ﹤0.01% |
11,400
-18,700
| -62% | -$89.7K |
|
|
TBI
12273
CALL
Trueblue
TBI
$311M
| $42.7K | ﹤0.01% |
2,400
+2,000
| +500% | +$37.4K |
|
|
BCOV
12274
PUT
DELISTED
Brightcove, Inc.
BCOV
| $42.7K | ﹤0.01% |
9,600
-43,600
| -82% | -$243K |
|
12275
CALL
Keros Therapeutics
KROS
$200M
| $42.7K | ﹤0.01% |
1,000
-17,400
| -95% | -$879K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.